Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Drug Company PI Date Risk List Available? Sort descending
Ribavirin Aurobindo Pharma Limited October 2018
VinCRIStine Sulfate Hospira, Inc. October 2019
Medroxyprogesterone Acetate (DEPO-PROVERA CI) Pfizer January 2017
Darunavir/Cobicistat (Prezcobix) Janssen September 2018
Abacavir/Lamivudine (Epzicom) GlaxoSmithKline May 2019
Tamoxifen Citrate Mylan Pharmaceuticals April 2013
Semaglutide (Ozempic) Novo Nordisk April 2019
Rifabutin (Mycobutin) Pfizer April 2018
Vorinostat (Zolinza) - New Merck January 2020
Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) Gilead Sciences August 2019
Rifampin Lannett Company Inc. March 2019
Isoniazid Macleods Pharmaceuticals Ltd August 2015
Clofazimine (Lamprene) Novartis January 2019
Isoniazid Sandoz Inc. October 2018
Abacavir Sulfate/Dolutegravir/Lamivudine (Triumeq) - New GlaxoSmithKline March 2020
Rifampicin Macleods Pharmaceuticals Limited December 2018
Pitavastatin (Livalo) - New Kowa October 2019
Bedaquiline (Sirturo) Janssen August 2019
Abacavir (Ziagen) GlaxoSmithKline June 2019
Ethambutol Macleods Pharmaceuticals Limited July 2019